United HealthCare Community Plan of Arizona policies, page 3

Search United HealthCare Community Plan of Arizona's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

386 public policies Substrate tracks for United HealthCare Community Plan of Arizona, by title.

United HealthCare Community Plan of Arizona policies
PolicyDetailsCodesSource
Durable Medical Equipment, Orthotics, Medical Supplies, and Repairs/ReplacementsCS032.AB · Effective May 1, 2026 · Medicaid7Original policy ↗
EdaravoneMedicaid1Original policy ↗
Elective Inpatient ServicesMedicaid—Original policy ↗
Electric Tumor Treatment Field TherapyCS146.N · Effective Sep 1, 2026 · Medicaid3Original policy ↗
Electrical and Ultrasonic Bone Growth StimulatorsMedicaid7Original policy ↗
Electrical Stimulation for the Treatment of Pain and Muscle RehabilitationCS036.Y · Effective May 1, 2026 · Medicaid41Original policy ↗
Electromagnetic Therapy for WoundsMedicaid3Original policy ↗
Elevidys® (Delandistrogene Moxeparvovec-Rokl)Medicaid1Original policy ↗
Emergency Department (ED) Facility Evaluation and Management (E&M) Coding PolicyEffective Sep 1, 2026 · Medicaid6Original policy ↗
Emergency Room Ancillary Services Policy, FacilityMedicaid2Original policy ↗
Encelto® (Revakinagene Taroretcel-Lwey) – Community Plan Medical Benefit Drug PolicyMedicaid1Original policy ↗
Enteral Nutrition (Oral and Tube Feeding)CS136.R · Effective May 1, 2026 · Medicaid20Original policy ↗
Entyvio® (Vedolizumab) – Community Plan Medical Benefit Drug PolicyMedicaid1Original policy ↗
Enzyme Testing for Acute Pancreatitis Policy, Professional and FacilityMedicaid7Original policy ↗
Epidural Steroid Injections for Spinal PainCS039.AB · Effective Jul 1, 2026 · Medicaid9Original policy ↗
Epiduroscopy, Epidural Lysis of Adhesions, and DiscographyCS040.P · Effective Feb 1, 2026 · Medicaid8Original policy ↗
Epithelial Cell Cytology Policy, Professional and FacilityEffective Sep 6, 2026 · Medicaid5Original policy ↗
Erythropoiesis-Stimulating AgentsMedicaid8Original policy ↗
Evaluation and Management (E/M) Policy, ProfessionalEffective Jan 1, 2023 · Medicaid24Original policy ↗
Evenity® (Romosozumab-Aqqg) – Community Plan Medical Benefit Drug PolicyMedicaid1Original policy ↗
Evkeeza® (Evinacumab-Dgnb) – Community Plan Medical Benefit Drug PolicyMedicaid1Original policy ↗
Exondys 51® (Eteplirsen)Medicaid1Original policy ↗
Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions and Soft Tissue IndicationsMedicaid6Original policy ↗
Facet Joint and Medial Branch Block Injections for Spinal PainCS178.J · Effective May 1, 2026 · Medicaid12Original policy ↗
Facility Billing Policy, FacilityMedicaid—Original policy ↗
Factor Mimetics and Rebalancing Agents for HemophiliaMedicaid4Original policy ↗
FcRn BlockersMedicaid4Original policy ↗
FDA Cleared or Approved Companion Diagnostic TestingMedicaid10Original policy ↗
Fecal Calprotectin Testing Policy, Professional and FacilityEffective Feb 1, 2026 · Medicaid—Original policy ↗
Flow Cytometry Policy, Professional and FacilityMedicaid13Original policy ↗
From-To Date Policy, ProfessionalMedicaid54Original policy ↗
Gastrointestinal Disorders Diagnostic ProceduresCS046.T · Effective Jul 1, 2026 · Medicaid9Original policy ↗
Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing for Infectious DiarrheaMedicaid3Original policy ↗
Gazyva® (Obinutuzumab)Medicaid1Original policy ↗
Gender Dysphoria TreatmentCS145.T · Effective Jul 1, 2026 · Medicaid135Original policy ↗
Gender to Diagnosis Code and Procedure Code Policy, ProfessionalMedicaid · AZ, DC, KS, MO, NC—Original policy ↗
Genetic Testing for Cardiac DiseaseCS048.V · Effective May 1, 2026 · Medicaid13Original policy ↗
Genetic Testing for Hereditary CancerMedicaid34Original policy ↗
Genetic Testing for Neurological DisordersCS165.K · Effective Sep 1, 2026 · Medicaid4Original policy ↗
Givlaari® (Givosiran) – Community Plan Medical Benefit Drug PolicyMedicaid1Original policy ↗
Glaucoma Surgical TreatmentsCS050.Y · Effective Sep 1, 2026 · Medicaid23Original policy ↗
Global Days Policy, ProfessionalMedicaid14Original policy ↗
Gonadotropin Releasing Hormone AnalogsMedicaid11Original policy ↗
Gynecomastia SurgeryCS051.R · Effective Jun 1, 2026 · Medicaid1Original policy ↗
Habilitation and Rehabilitation Therapy (Occupational, Physical, and Speech)CS164.M · Effective Aug 1, 2026 · Medicaid55Original policy ↗
Hearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-ImplantableCS052.V · Effective Jun 1, 2026 · Medicaid65Original policy ↗
Hemgenix® (Etranacogene Dezaparvovec-Drlb) – Community Plan Medical Benefit Drug PolicyMedicaid1Original policy ↗
Hepatic Fibrosis Testing for Chronic Liver Disease Policy, Professional and FacilityEffective Oct 1, 2026 · Medicaid7Original policy ↗
Hereditary Angioedema (HAE), Treatment and ProphylaxisMedicaid4Original policy ↗
Home Health Services Policy, ProfessionalEffective Mar 12, 2024 · Medicaid24Original policy ↗

Back to United HealthCare Community Plan of Arizona

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.